IGM Biosciences, Inc. Total Assets
IGM Biosciences, Inc. had Total Assets of $106.99 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2025-07-31
- 2025-06-30: Assets $106.99M.
- 2025-03-31: Assets $206.89M.
- 2024-12-31: Assets $265.71M.
- 2024-09-30: Assets $304.51M.
| Period end | Assets |
|---|---|
| 2025-06-30 | $106.99M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $206.89M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $265.71M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $304.51M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $336.50M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $376.13M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $423.41M 10-K · filed 2025-03-06 |
| 2023-09-30 | $474.35M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $480.66M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $462.74M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $513.50M 10-K · filed 2024-03-07 |
| 2022-09-30 | $540.94M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $582.20M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $257.74M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $298.13M 10-K · filed 2023-03-30 |
| 2021-09-30 | $332.23M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $350.66M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $380.47M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $408.63M 10-K · filed 2022-03-29 |
| 2020-09-30 | $211.72M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $229.06M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $243.15M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $261.35M 10-K · filed 2021-03-30 |
| 2019-09-30 | $269.86M 10-Q · filed 2019-11-07 |
| 2018-12-31 | $3.98M 10-K · filed 2020-03-26 |